about
The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking.Single-domain antibodies that compete with the natural ligand fibroblast growth factor block the internalization of the fibroblast growth factor receptor 1.Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan.Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization.Cadherins and the tumour progression: is it all in a switch?Multitasking in tumor progression: signaling functions of cell adhesion molecules.The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signallingEndothelial cadherins and tumor angiogenesis.Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells.Diverse functions of myosin VI elucidated by an isoform-specific α-helix domainThe adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells.The functional role of cell adhesion molecules in tumor angiogenesis.Neural cell adhesion molecule in cancer: expression and mechanisms.Immunoglobulin-like cell adhesion molecules: novel signaling players in epithelial ovarian cancer.The Pleiotropic Role of L1CAM in Tumor VasculatureOvarian cancer stem cells: still an elusive entity?Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer.Adhesion molecule signalling: not always a sticky business.The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium.Neural cell adhesion molecule regulates the cellular response to fibroblast growth factor.Microarray profiling of L1-overexpressing endothelial cells reveals STAT3 activation via IL-6/IL-6Rα axis.Antitumorigenic and antiinsulinogenic effects of calcitriol on insulinoma cells and solid beta-cell tumors.Exogenous fibroblast growth factor-2 induces a transformed phenotype in vascular kaposi's sarcoma-like cells.FGF-2 promotes disassembly of actin cytoskeleton and shape changes in murine vascular cells.Fibronectin modulates endothelial response to HIV type 1 Tat.PMA-induced down-regulation of the receptor for alpha 2-macroglobulin in human U937 cells.PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes.Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells.L1 in tumor vasculature.The control of tumor vessels: what you would not expect from a neural adhesion molecule.Molecular pathways involved in the antineoplastic effects of calcitriol on insulinoma cells.Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts.Extensive and systematic rewiring of histone post-translational modifications in cancer model systems.CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputs.Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts.Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte InfiltrationLoss of Neural Cell Adhesion Molecule Induces Tumor Metastasis by Up-regulating LymphangiogenesisEndothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalizationResponse of bovine endothelial cells to FGF-2 and VEGF is dependent on their site of origin: Relevance to the regulation of angiogenesis
P50
Q33589792-C03A013E-5674-4507-AD6E-EC7ED9831523Q33888746-078AAD39-07E4-4178-BEF4-CB3C8DEC2CFEQ34173001-C352794E-D05B-48B7-8F3C-F952EC95AAEEQ34311544-D34F8257-A52C-4048-B23F-D88D3EE5D9D7Q34502753-B47E495A-1A38-41B4-A127-971EF5E5D1B2Q35778224-D6B595F9-2E5F-4086-A762-840BB067BBBFQ36038778-A71B56C6-524A-41B9-B33D-819BA3B7060CQ36300450-6B2ED9AB-6581-4481-A2CB-C26F605DBC23Q36851279-E76EDBB7-782C-439C-8FC4-EBEB786A8A1EQ37135682-69CD6534-12A4-416D-B56A-6EBB1C54383EQ37149336-253446D8-6AF2-42CC-8D93-2F5779034F3EQ37501507-794E397D-7720-4C0F-A89B-19C21758AF8EQ37657290-4174C331-A521-4FD0-BD34-D01F90111157Q37677289-C195BCCD-4477-439B-9324-6CD0F5E89EC7Q37690651-97FDB312-DF2B-46BC-9825-EE71C00E33F9Q37713683-21F39382-26A4-4DF1-B166-E1F1B4B337E4Q37739177-B56E2380-D821-40EF-BA5C-1F47B0EE0412Q37846527-3AC0F16E-C0C9-4EE6-BBA9-CCD7A3159812Q40012147-5BA53B1A-3E97-492A-8B05-C4107DCCD8B0Q40043897-CCFB8EF5-D494-45A2-9A23-6EDEA0A40AA5Q40411887-3119360D-6F84-43F9-95AA-F3773F2714D9Q40703101-F0190CCB-CDF9-4554-A2A3-65B80AEA6C80Q40797997-5D70CFB8-FFB9-430C-A114-217BAD79DB2DQ40820516-E4CD4CB1-C0C7-46ED-9AB6-488687778FFDQ41085869-4240098B-7F75-413E-8CC2-30D397CEB4BFQ41380094-8291696B-EF12-493D-B826-9899C9FC3483Q42177054-53C80DD0-9729-46AA-AE77-1606A63771F9Q42500531-973A9E32-0DD9-42DD-B9BC-E65837D276A9Q42594330-BC6DB0EC-304B-47CC-B526-2D2EF5E77E7FQ42732155-7B43F6BD-25C9-47E1-9F59-C2D910556F84Q44405094-EDDB2F01-5A2B-4DEA-B52B-316200E491E1Q48303976-3845B725-59C9-4B7E-87EE-140E46B15748Q52332024-2A63CBE3-32C8-4850-84BF-C61097EE9EB3Q52649982-907EC6D4-F7F8-4F14-8147-6CBB89E2F8AFQ54410738-8E03D917-ED64-4C68-8FF8-7BED9BDC533EQ55181360-D1BBF372-D6A5-4990-A4E6-E1B5C5AB0CC7Q56942466-1EC61A20-C467-4E22-AD53-C9E00968FDB2Q57374728-A9A257F0-E078-4189-B79E-49F202414CA9Q57964057-9689D5E4-08C7-407E-83CB-C24270D77279Q58323579-E7F88C70-701A-4D86-9CC9-D6073A1B7B01
P50
description
forsker
@nb
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
U. Cavallaro
@ast
U. Cavallaro
@nl
Ugo Cavallaro
@en
Ugo Cavallaro
@es
Ugo Cavallaro
@nb
type
label
U. Cavallaro
@ast
U. Cavallaro
@nl
Ugo Cavallaro
@en
Ugo Cavallaro
@es
Ugo Cavallaro
@nb
altLabel
U. Cavallaro
@en
prefLabel
U. Cavallaro
@ast
U. Cavallaro
@nl
Ugo Cavallaro
@en
Ugo Cavallaro
@es
Ugo Cavallaro
@nb
P106
P31
P496
0000-0002-0884-6460